Svensk vaccinutvecklare får 24 miljoner av brittiskt forskningsprogram

Abera Bioscience får upp till motsvarande cirka 24 miljoner kronor i finansiering från ett brittiskt program inriktat på vacciner som ska stoppa epidemier i låg- och medelinkomstländer.

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic have achieved just that, and they are thus making a significant contribution to the history of Swedish medicine. He is now being awarded the Research!Sweden Award 2023.

New diagnostic rules raise concerns

In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagnostics (IVDR). They argue that it may create significant differences between regions, and patients may be affected.

Meeting with focus on South Korea and Japan’s life sciences

Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage during a webcast seminar.

Sydkoreas och Japans life science i fokus på möte

Stora, komplexa och spännande. Så beskriver Britta Stenson, Business Sweden, Japans och Sydkoreas marknader för life science, som stod i centrum under ett webbsänt seminarium.

Karolinska sjätte bästa sjukhus i världen enligt ny rankning

Den amerikanska tidskriften Newsweek rankar varje år världens bästa sjukhus. 2023 finns Karolinska universitetssjukhuset på sjätte plats.

A surprising discovery about the immune system in cases of cancer

Professor Göran Jönsson is trying to understand why some patients benefit from immunotherapies while others don’t. A couple of years ago, he made a surprising discovery about the function of the immune system.

Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”

”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigård writes in a column.

“We are Europe’s hotspot in life science”

The Medicon Valley Alliance has worked for competence development in life science in Denmark and Sweden for a quarter of a century. Anette Steenberg, CEO, sees the anniversary as a recognition of MVA’s explosive power.

Covid-19 ger allt snabbare insjuknande – omikron kortar inkubationstiden

Sedan virusvarianten omikron blev helt dominerade i spridningen av covid-19 har inkubationstiden sjunkit kraftigt, till bara drygt tre dygn, enligt en ny metastudie.

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and Covid-19. However, not one single institute in the entire Nordic region is able to certify

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work against solid tumours. At Gothenburg-based Elicera, they are working relentlessly to succeed in that field as well. “It is the largest field, and the potential is enormous,” says the company’s CEO Jamal El-Mosleh.

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network will generate as many versions as the people you ask. Most likely, we will miss many

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure that new medicines will be available for all citizens in Europe, writes Marie Gårdmark in a column.

GMS i samarbete med tyskt center inom precisionsmedicin

Centers for Personalized Medicine i Tyskland är ett av Europas ledande center inom precisionsmedicin. Nu går de in i ett samarbete med Genomic Medicine Sweden.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Oncopeptides cancerläkemedel i nationella riktlinjer i USA

Oncopeptides har fått sitt första läkemedel Pepaxto infört i de kliniska riktlinjerna i USA för behandling av cancer i benmärgen.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to fundamental changes to the regulatory system? In a column Marie Gårdmark, CEO and Senior Consultant at RegSmart Life Science, develops her views on this subject.

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Hälften av dödsfallen i covid-19 har skett på vårdboenden

Av alla dödsfall som det nya coronaviruset skördat i Europa har omkring hälften drabbat personer som bott på vårdboenden. Detta enligt en ny rapport som The Guradian rapporterar om.

Lunds universitet hoppas att AI kan underlätta för patologer

I ett treårigt projekt har forskare vid Lunds universitet och Matematikcentrum undersökt hur artificiell intelligens, AI, kan avlasta och underlätta patologernas arbete och snabba på diagnostiseringen.

Krönika: Collaboration across borders